AMBS looking at a chart reversal here after

New Post Public Reply Private Reply Replies (1) Message Board
TradeForProfits

AMBS looking at a chart reversal here after consolidating last couple of days.

Amarantus Engages BD Biosciences for Development of Alzheimer’s Diagnostic

RELATED QUOTES

Symbol Price Change
AMBS 0.0385

SUNNYVALE, Calif.--(BUSINESS WIRE)--

Amarantus BioScience Holdings, Inc. ( AMBS ), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, today announced it has signed a laboratory services agreement with BD Biosciences, a segment of BD (Becton, Dickinson and Company) , a leading global medical technology company, under which BD’s BD Biosciences Custom Technology Team will perform sample analysis on Amarantus’ LymPro Test® for Alzheimer’s disease. Financial terms were not disclosed.

“The LymPro Test is potentially the first available blood test for Alzheimer’s disease,” said Gerald E. Commissiong, President & CEO of Amarantus. “With this agreement, we expect to have initial data available in the third quarter of 2013, and now have the capabilities required to place LymPro on a path for commercialization in 2014.”

Amarantus and BD Biosciences will be focused on verifying the analytical performance characteristics of LymPro necessary to achieve reproducibility of the assay. Over time, Amarantus expects to execute multiple clinical studies and begin worldwide sales of LymPro as the first diagnostic blood test for Alzheimer’s disease.

About Amarantus

Amarantus is a development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics surrounding the intellectual property and proprietary technologies it owns to treat and/or diagnose Parkinson's disease, Traumatic Brain Injury, Ischemic Heart Disease and other human diseases. The Company owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. The Company also is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property and licenses for the diagnosis of Parkinson's disease and Alzheimer's disease. For further information please visit  www.Amarantus.com .

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about the possible progress of the MANF technology in testing for Parkinson’s disease, as well as statements about expectations, plans and prospects of the development of Amarantus' diagnostic product candidates for Parkinson’s and Alzheimer’s disease. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including the risks associated with development of therapeutic drug candidates, as well as the risks, uncertainties and assumptions relating to the development of Amarantus' new product candidates, including those identified under "Risk Factors" in Amarantus' most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q and in other filings Amarantus periodically makes with the SEC. Actual results may differ materially from those contemplated by these forward-looking statements Amarantus does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date of this presentation.

Contact:
Investor/Media Contacts
Amarantus
Russell Miller
Director of Investor Relations
310-386-2058
ir@amarantus.com
or
LHA
Don Markley, Senior Vice President
310-691-7100
dmarkley@lhai.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

How Track Rabbit Levels the Playing Field for Small Motorsport Ventures

Updated Category News Views 3

Fielding Opportunities in a Revved-Up Market You're knee-deep in grease and exhaust, keeping your motorsport enterprise alive against the big dogs without losing grip on the little guy's budget. What if I told you there's a service out there talking your language – combining marketing prowess with AI smarts for as low as $350 a month? That's ALIVE and Track Rabbit...

Continue Reading
Former OB/GYN Faces $9M Verdict After Negligence Trial

Updated Category News Views 5

A Tragic Verdict Worth Millions In the heart-wrenching case of former OB/GYN Arthur Park, the verdict has fallen like a ton of bricks. A jury in Bakersfield, California, has determined that Park's negligent care led to fatalities, resulting in a mammoth $9.25 million payout to two grief-stricken families. It's a bitter pill to swallow for Arthur Park, but an expected...

Continue Reading
Top Seedz: Seeds Drive Growth in Crowded Cracker Market

Updated Category News Views 2

Breaking the Cracker Mold with Seeds Ever thought crackers could be more than just a canvas for cheese? Well, Top Seedz out of Buffalo is redefining the snack aisle with its seed-centric approach. In a whopping $25 billion global cracker market, this woman-owned outfit is carving out its niche by flipping conventional recipes on their heads. They're not just tossing seeds...

Continue Reading
Labcorp Scoops Up BioReference Health For $722M+

Updated Category News Views 7

Picture this: You’re a big fish like Labcorp ready to feast on smaller catches. That’s exactly what’s rolling out as OPKO Health cuts a deal to offload a chunk of its BioReference Health assets to Labcorp for a tidy $722 million in cash. Assets on the Move OPKO’s BioReference Health has long been a player in the clinical testing world, with a focus on services...

Continue Reading
Duolingo Faces Class Action: Investors Brace for Impact

Updated Category News Views 4

Going Beyond Language Learning Hype Listen, it's not every day you wake up to a lawsuit calling out one of those seemingly indestructible tech darlings. Well, Duolingo (NASDAQ: DUOL) is caught in the crosshairs now. They face allegations of pulling the wool over investors' eyes about their monetization and growth tactics. If you snapped up some stock between May 2, 2025,...

Continue Reading
Sony's Game-Changing Sensor Reshapes Medical Endoscopy

Updated Category News Views 3

In a world where medical tech innovation can make the difference between life and death, Sony’s latest feat will turn some heads in the healthcare industry. This ain’t about another PlayStation release; we’re talking the IMX742 CMOS image sensor crafted for single-use endoscopes. As far as breakthroughs go, the microscopic square sensor packs a surprising punch by...

Continue Reading
Amcor's Q3 2026 Results Loom: What's at Stake?

Updated Category News Views 3

Anticipation Builds for Amcor's Q3 2026 Financials Well, here we are again, staring down the barrel of another quarterly earnings report from Amcor plc (NYSE: AMCR). They've circled November 4th, 2026, in red on their calendars to dish out the numbers after the U.S. market's last bell rings. Investors, analysts, and the peanut gallery will be tuning in, and why not? At a...

Continue Reading
ILS and Anduin Join Forces to Streamline Fundraising

Updated Category News Views 1

Big Moves in Legal Tech and Fundraising In the world of investing, where technology is always a step ahead, Intelligent Legal Solutions (ILS) and Anduin are cooking up a storm with their latest partnership announcement. Targeting private markets fund managers and law firms, these two tech players aim to ease the layered chaos that comes with fundraising by integrating...

Continue Reading
India's Bharat RE 2026 Amidst Global Energy Stakes

Updated Category News Views 5

India's Ambitious Energy Vision Diving right into it, India's ready to slap its mighty stamp on the global clean energy landscape. This grand affair, Bharat Renewable Energy Summit & Expo 2026, is calling in the big wigs from over 130 countries to New Delhi. It's not a casual gathering either—it's a serious play to crank up investment and tech alliances in renewable...

Continue Reading
Epson's Robotics Innovation Takes Center Stage at ASSEMBLY

Updated Category News Views 7

No More Robots in the Background Walking into The ASSEMBLY Show 2026, you'd think robots had finally emerged from their hushed backstage roles and are now ready to claim their rightful place in the spotlight. Epson's leading the charge with their fresh AX6 collaborative robot, a machine that might just change the game for good. AX6 Cobot: The New Kid on the Block Epson's...

Continue Reading

Top 5 Most Recently Viewed Articles

FastPassCorp Reports Strong Equity Recovery and Order Growth

Updated Category News Views 150

FastPassCorp Reports Strong Equity Recovery and Growth Opportunities In a recent announcement, FastPassCorp A/S highlighted notable developments in its financial performance and market presence. The company has successfully recovered its equity, with significant improvements reported in its recent financial results. This positive trend not only reflects the company's...

Continue Reading
Brera Holdings Strengthens Community Bonds Through Juve Stabia

Updated Category News Views 244

Building Strong Community Ties with Juve Stabia Brera Holdings PLC, an international holding company, is making strides in enhancing its connection with S.S. Juve Stabia Srl, poised to be a powerful partnership focused on community development. The recent meeting involving Brera Holdings' Executive Chairman, Daniel McClory, with local officials underscores a commitment to...

Continue Reading
Market Update: Futures Decline as Nvidia's Outlook Dims

Updated Category News Views 240

Market Overview European and US equity futures have dipped following Nvidia Corp.'s disappointing outlook, which has dampened the momentum of the global AI rally. Contracts for the Euro Stoxx 50 fell by 0.2%, while futures on the Nasdaq 100 Index decreased by 0.5%. In Asia, a benchmark index also slipped by 0.2%, significantly influenced by chipmakers like Taiwan...

Continue Reading
Aldebaran Resources Advances Joint Venture with Nuton Holdings

Updated Category News Views 142

Aldebaran Resources Moves Forward with Nuton Holdings Aldebaran Resources Inc. is making strides in its partnership with Nuton Holdings Ltd., which is a joint venture with Rio Tinto. Recently, it was confirmed that Nuton will proceed with its second payment of USD 20 million as part of their Option to Joint Venture Agreement regarding the Altar project. Understanding the...

Continue Reading
Rhythm Pharmaceuticals Plans $150 Million Stock Offering to Fund Growth

Updated Category News Views 176

Rhythm Pharmaceuticals Unveils New Stock Offering Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a dedicated biopharmaceutical company focused on improving the lives of patients with rare neuroendocrine diseases, is excited to announce its proposed public offering of $150 million of common stock. This offering is designed to bolster the company’s growth and innovation in...

Continue Reading